Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Argus Health
Cantor Fitzgerald
Federal Trade Commission

Generated: October 19, 2017

DrugPatentWatch Database Preview

PRANDIN Drug Profile

« Back to Dashboard

Which patents cover Prandin, and when can generic versions of Prandin launch?

Prandin is a drug marketed by Gemini Labs Llc and is included in one NDA.

The generic ingredient in PRANDIN is repaglinide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the repaglinide profile page.

Summary for Tradename: PRANDIN

US Patents:0
Suppliers / Packagers: see list5
Bulk Api Vendors: see list66
Patent Applications: see list5,341
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRANDIN at DailyMed

Pharmacology for Tradename: PRANDIN

Drug ClassGlinide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gemini Labs Llc
TABLET;ORAL020741-001Dec 22, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe
Gemini Labs Llc
TABLET;ORAL020741-002Dec 22, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe
Gemini Labs Llc
TABLET;ORAL020741-003Dec 22, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PRANDIN

Paragraph IV (Patent) Challenges for PRANDIN

Drugname Dosage Strength RLD Submissiondate
repaglinideTablets0.5 mg, 1 mg and 2 mgPrandin2/10/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Johnson and Johnson
Chinese Patent Office
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus